Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

4.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.9K
Apoptosis01:30

Apoptosis

17.2K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
17.2K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

3.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
Bone Remodeling01:40

Bone Remodeling

41.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
41.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Recommendations for Remote Robotic Assisted Surgery From the CRSA 2025 International Consensus Conference.

World journal of surgery·2026
Same author

Funding, service and resource gaps at primary health care centres in Iraq.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit·2026
Same author

Bioavailability and growth performance of zinc sulfate, zinc glycinate, zinc amino acid hydrate, and zinc methionine hydroxy analog in male broilers.

Poultry science·2026
Same author

Funding, service and resource gaps at primary health care centres in Iraq.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit·2026
Same author

Mapping relative proximity within an internalizing symptoms network.

Journal of anxiety disorders·2026
Same author

Evaluating Large Language Models for Translating Multimodal Phenotype Documentations into Executable EHR Phenotyping Algorithms.

Research square·2026

Related Experiment Video

Updated: Apr 16, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

15.0K

Reveromycin A-Induced Apoptosis in Osteoclasts Is Not Accompanied by Necrosis.

Brittany Mead1, Heather Morgan1, Alyssa Mann-Knowlton1

  • 1Division of Natural Sciences, Department of Biology, Indiana Wesleyan University, South Washington Street, Marion, Indiana.

Journal of Cellular Biochemistry
|March 11, 2015
PubMed
Summary

Reveromycin A selectively induces apoptosis in osteoclasts, not osteoblasts, offering a potential osteoporosis therapy. This natural product triggers programmed cell death without causing necrosis, making it a promising bone antiresorptive agent.

Keywords:
APOPTOSISNECROSISOSTEOCLASTREVEROMYCIN A

More Related Videos

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
07:51

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Published on: March 18, 2019

6.5K
A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

12.2K

Related Experiment Videos

Last Updated: Apr 16, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

15.0K
Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
07:51

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Published on: March 18, 2019

6.5K
A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

12.2K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Cell Biology

Background:

  • Osteoporosis is a bone disease characterized by low bone mass and structural deterioration.
  • Osteoclasts are responsible for bone resorption, while osteoblasts are responsible for bone formation.
  • Reveromycin A (RM-A) is a natural product with potential therapeutic applications for osteoporosis due to its selective action on osteoclasts.

Purpose of the Study:

  • To investigate the intracellular mechanisms by which Reveromycin A induces apoptosis in mature osteoclasts.
  • To determine if RM-A induces necrosis in osteoclasts.
  • To assess the impact of RM-A on osteoclast differentiation markers.

Main Methods:

  • RAW264.7 murine macrophages were differentiated into osteoclasts using receptor activator of nuclear factor kappa B ligand (RANKL).
  • Osteoclasts were treated with 10 μM Reveromycin A at pH 5.5 for varying durations (2-48 hours).
  • Apoptosis was measured by caspase 3 activity, necrosis by lactate dehydrogenase release, and protein levels by Western blot (caspase 9, Bcl-XL, NFκB).

Main Results:

  • Reveromycin A induced significant apoptosis in osteoclasts, peaking at 4-6 hours, with no significant necrosis observed.
  • Western blot analysis revealed activation of caspase 9 but no significant change in Bcl-XL.
  • NFκB levels increased during osteoclast differentiation but remained stable during RM-A treatment.

Conclusions:

  • Reveromycin A selectively induces apoptosis in osteoclasts via the intrinsic caspase pathway.
  • The absence of necrosis suggests limited off-target effects on neighboring bone cells.
  • RM-A's specific cell death profile supports its potential as a bone antiresorptive agent for osteoporosis treatment.